Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis.
作者信息
Muftuoglu Ilkay Kilic, Akova Yonca A, Gungor Sirel G
机构信息
Department of Ophthalmology, Istanbul Training and Research Hospital, Istanbul 34098, Turkey.
Department of Ophthalmology, Bayindir Kavaklidere Hospital, Ankara 06490, Turkey.
出版信息
Int J Ophthalmol. 2016 Apr 18;9(4):634-5. doi: 10.18240/ijo.2016.04.26. eCollection 2016.
Abstract
摘要
相似文献
1
Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis.
Int J Ophthalmol. 2016 Apr 18;9(4):634-5. doi: 10.18240/ijo.2016.04.26. eCollection 2016.
2
Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates.
Case Rep Ophthalmol. 2016 Mar 8;7(1):135-40. doi: 10.1159/000444784. eCollection 2016 Jan-Apr.
3
Cyclosporin A eye drop and subepithelial adenoviral keratoconjunctivitis infiltrates.
Tunis Med. 2019 May;97(5):639-643.
4
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Arch Ophthalmol. 2001 Oct;119(10):1487-91. doi: 10.1001/archopht.119.10.1487.
5
Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Cornea. 2010 Jun;29(6):638-40. doi: 10.1097/ICO.0b013e3181c33034.
6
[Clinical and immunological comparisons of therapeutic regimens for corneal infiltrates secondary to adenoviral keratoconjunctivitis].
Vestn Oftalmol. 2015 Jul-Aug;131(4):49-55. doi: 10.17116/oftalma2015131449-55.
7
Re: Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis.
Cornea. 2018 Jul;37(7):e32. doi: 10.1097/ICO.0000000000001458.
8
[Adenoviral keratoconjunctivitis].
J Fr Ophtalmol. 2010 Oct;33(8):586-92. doi: 10.1016/j.jfo.2010.07.003. Epub 2010 Aug 17.
9
[Adenoviral keratoconjunctivitis].
Ophthalmologe. 2015 May;112(5):459-69; quiz 469-71. doi: 10.1007/s00347-015-0006-x.
10
Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates.
Int J Ophthalmol. 2019 Sep 18;12(9):1420-1425. doi: 10.18240/ijo.2019.09.08. eCollection 2019.
引用本文的文献
1
Evaluating the Efficacy of Topical Tacrolimus Alone and in Combination with Prednisolone for Treating Subepithelial Infiltrates in Epidemic Keratoconjunctivitis.
Biomedicines. 2025 Apr 8;13(4):895. doi: 10.3390/biomedicines13040895.
2
Sequelae of microsporidial keratoconjunctivitis and its management.
Indian J Ophthalmol. 2021 Jun;69(6):1537-1543. doi: 10.4103/ijo.IJO_1971_20.
3
Pentacam corneal densitometry-guided treatment of adenoviral corneal subepithelial infiltrates: a comparative study between transepithelial phototherapeutic keratectomy and topical tacrolimus.
Int Ophthalmol. 2021 Jan;41(1):67-77. doi: 10.1007/s10792-020-01553-8. Epub 2020 Aug 27.
4
Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions.
Clin Ophthalmol. 2020 Mar 17;14:837-852. doi: 10.2147/OPTH.S207976. eCollection 2020.
5
Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates.
Int J Ophthalmol. 2019 Sep 18;12(9):1420-1425. doi: 10.18240/ijo.2019.09.08. eCollection 2019.
6
Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.
Indian J Ophthalmol. 2019 May;67(5):594-598. doi: 10.4103/ijo.IJO_1352_18.
7
Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction.
Int J Ophthalmol. 2018 Apr 18;11(4):593-600. doi: 10.18240/ijo.2018.04.09. eCollection 2018.
本文引用的文献
1
Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
Cornea. 2011 Sep;30(9):958-61. doi: 10.1097/ICO.0b013e31820cd607.
2
Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Cornea. 2010 Jun;29(6):638-40. doi: 10.1097/ICO.0b013e3181c33034.
3
Topical cyclosporine in the management of shield ulcers.
Cornea. 2004 Mar;23(2):194-200. doi: 10.1097/00003226-200403000-00014.
4
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Arch Ophthalmol. 2001 Oct;119(10):1487-91. doi: 10.1001/archopht.119.10.1487.
5
[Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study].
Ophthalmologe. 2000 Nov;97(11):764-8. doi: 10.1007/s003470070025.
6
The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.
Arch Ophthalmol. 1998 Jul;116(7):900-5. doi: 10.1001/archopht.116.7.900.
7
Corneal histology after epidemic keratoconjunctivitis.
Arch Ophthalmol. 1978 Nov;96(11):2085-8. doi: 10.1001/archopht.1978.03910060465016.
Zotero 插件